FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313365264> ?p ?o ?g. }

• W4313365264 abstract "The paucity of SARS-CoV-2-specific virulence factors has greatly hampered the therapeutic management of patients with COVID-19 disease. Although available vaccines and approved therapies have shown tremendous benefits, the continuous emergence of new variants of SARS-CoV-2 and side effects of existing treatments continue to challenge therapy, necessitating the development of a novel effective therapy. We have previously shown that our developed novel single-stranded DNA aptamers not only target the trimer S protein of SARS-CoV-2, but also block the interaction between ACE2 receptors and trimer S protein of Wuhan origin, Delta, Delta plus, Alpha, Lambda, Mu, and Omicron variants of SARS-CoV-2. We herein performed in vivo experiments that administer the aptamer to the lungs by intubation as well as in vitro studies utilizing PBMCs to prove the efficacy and safety of our most effective aptamer, AYA2012004_L.In vivo studies were conducted in transgenic mice expressing human ACE2 (K18hACE2), C57BL/6J, and Balb/cJ. Flow cytometry was used to check S-protein expressing pseudo-virus-like particles (VLP) uptake by the lung cells and test the immuogenicity of AYA2012004_L. Ames test was used to assess mutagenicity of AYA2012004_L. RT-PCR and histopathology were used to determine the biodistribution and toxicity of AYA2012004_L in vital organs of mice.We measured the in vivo uptake of VLPs by lung cells by detecting GFP signal using flow cytometry. AYA2012004_L specifically neutralized VLP uptake and also showed no inflammatory response in mice lungs. In addition, AYA2012004_L did not induce inflammatory response in the lungs of Th1 and Th2 mouse models as well as human PBMCs. AYA2012004_L was detectable in mice lungs and noticeable in insignificant amounts in other vital organs. Accumulation of AYA2012004_L in organs decreased over time. AYA2012004_L did not induce degenerative signs in tissues as seen by histopathology and did not cause changes in the body weight of mice. Ames test also certified that AYA2012004_L is non-mutagenic and proved it to be safe for in vivo studies.Our aptamer is safe, effective, and can neutralize the uptake of VLPs by lung cells when administered locally suggesting that it can be used as a potential therapeutic agent for COVID-19 management." @default.
• W4313365264 created "2023-01-06" @default.
• W4313365264 creator A5006095146 @default.
• W4313365264 creator A5013560664 @default.
• W4313365264 creator A5016780340 @default.
• W4313365264 creator A5037713145 @default.
• W4313365264 creator A5045936532 @default.
• W4313365264 creator A5052060379 @default.
• W4313365264 creator A5055174519 @default.
• W4313365264 creator A5058204538 @default.
• W4313365264 creator A5065713709 @default.
• W4313365264 creator A5071009209 @default.
• W4313365264 creator A5075224901 @default.
• W4313365264 creator A5086041567 @default.
• W4313365264 date "2022-12-30" @default.
• W4313365264 modified "2023-10-18" @default.
• W4313365264 title "Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease" @default.
• W4313365264 cites W1459486101 @default.
• W4313365264 cites W1966389450 @default.
• W4313365264 cites W1972081326 @default.
• W4313365264 cites W2005156172 @default.
• W4313365264 cites W2049286784 @default.
• W4313365264 cites W2058829787 @default.
• W4313365264 cites W2062229879 @default.
• W4313365264 cites W2068099179 @default.
• W4313365264 cites W2068545703 @default.
• W4313365264 cites W2100181290 @default.
• W4313365264 cites W2101853634 @default.
• W4313365264 cites W2102109092 @default.
• W4313365264 cites W2116641087 @default.
• W4313365264 cites W2120740535 @default.
• W4313365264 cites W2148027724 @default.
• W4313365264 cites W2153541811 @default.
• W4313365264 cites W2166141110 @default.
• W4313365264 cites W2169429712 @default.
• W4313365264 cites W2237586381 @default.
• W4313365264 cites W2286131644 @default.
• W4313365264 cites W2547782348 @default.
• W4313365264 cites W2610489194 @default.
• W4313365264 cites W2953667108 @default.
• W4313365264 cites W2982687902 @default.
• W4313365264 cites W3008827533 @default.
• W4313365264 cites W3010096359 @default.
• W4313365264 cites W3010930696 @default.
• W4313365264 cites W3029765016 @default.
• W4313365264 cites W3036617521 @default.
• W4313365264 cites W3039616886 @default.
• W4313365264 cites W3096806149 @default.
• W4313365264 cites W3099347064 @default.
• W4313365264 cites W3107191813 @default.
• W4313365264 cites W3127568233 @default.
• W4313365264 cites W3134432287 @default.
• W4313365264 cites W3134798193 @default.
• W4313365264 cites W3162301887 @default.
• W4313365264 cites W3165479483 @default.
• W4313365264 cites W3168006398 @default.
• W4313365264 cites W3192612429 @default.
• W4313365264 cites W3200808056 @default.
• W4313365264 cites W3211876069 @default.
• W4313365264 cites W3214495736 @default.
• W4313365264 cites W4200030469 @default.
• W4313365264 cites W4200508731 @default.
• W4313365264 cites W4205720264 @default.
• W4313365264 cites W4214932124 @default.
• W4313365264 cites W4214936510 @default.
• W4313365264 cites W4221107196 @default.
• W4313365264 cites W4224057004 @default.
• W4313365264 cites W4224275281 @default.
• W4313365264 cites W4226420765 @default.
• W4313365264 cites W4281709648 @default.
• W4313365264 cites W4281834416 @default.
• W4313365264 doi "https://doi.org/10.1186/s12985-022-01943-7" @default.
• W4313365264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36581924" @default.
• W4313365264 hasPublicationYear "2022" @default.
• W4313365264 type Work @default.
• W4313365264 citedByCount "2" @default.
• W4313365264 countsByYear W43133652642023 @default.
• W4313365264 crossrefType "journal-article" @default.
• W4313365264 hasAuthorship W4313365264A5006095146 @default.
• W4313365264 hasAuthorship W4313365264A5013560664 @default.
• W4313365264 hasAuthorship W4313365264A5016780340 @default.
• W4313365264 hasAuthorship W4313365264A5037713145 @default.
• W4313365264 hasAuthorship W4313365264A5045936532 @default.
• W4313365264 hasAuthorship W4313365264A5052060379 @default.
• W4313365264 hasAuthorship W4313365264A5055174519 @default.
• W4313365264 hasAuthorship W4313365264A5058204538 @default.
• W4313365264 hasAuthorship W4313365264A5065713709 @default.
• W4313365264 hasAuthorship W4313365264A5071009209 @default.
• W4313365264 hasAuthorship W4313365264A5075224901 @default.
• W4313365264 hasAuthorship W4313365264A5086041567 @default.
• W4313365264 hasBestOaLocation W43133652641 @default.
• W4313365264 hasConcept C104317684 @default.
• W4313365264 hasConcept C111599444 @default.
• W4313365264 hasConcept C128972844 @default.
• W4313365264 hasConcept C150903083 @default.
• W4313365264 hasConcept C153911025 @default.
• W4313365264 hasConcept C159047783 @default.
• W4313365264 hasConcept C203014093 @default.
• W4313365264 hasConcept C207001950 @default.
• W4313365264 hasConcept C2777807558 @default.

• next